Back to Authors

Rana, Rimki

Mayo Clinic

Mayo Clinic

Citations 2

Late-Onset Acute Lung Injury in Mechanically Ventilated Postoperative Patients
Rana, Rimki, Gajić, Ognjen, Hubmayr, Rolf D., Gajic, Ognjen , Brown, D.R.

Journal of Investigative Medicine | May 25, 2023 | Volume: 52 | Issue: 2_suppl_part_2 | Pages: 382-382

10.1177/108155890405202s104 Get It

Transfusion-related Acute Lung Injury in the Critically Ill
Rana, Rimki, Winters, Jeffrey L. , Yılmaz, Murat , Méndez, José L. , Rickman, Otis B. , O’Byrne, Megan M., Evenson, Laura K., Malinchoc, Michael, DeGoey, Steven R., Afessa, Bekele, Hubmayr, Rolf D., Moore, S. Breanndan, Gajic, Ognjen , Winters, Jeffrey L

American Journal of Respiratory and Critical Care Medicine | July 12, 2007 | Volume: 176 | Issue: 9 | Pages: 886-891

10.1164/rccm.200702-271oc Get It

Abstract Rationale Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. Objectives To compare patient and transfusion risk factors between patients who do and do not develop ALI. Methods In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Measurements and Main Results Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37–18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32–17.86) and anti–HLA class II antibodies (OR, 3.08; 95% CI, 1.15–8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Conclusions Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.